Biotech firm's COVID-19 detection kit greenlighted for launch

It can now be used directly by laboratories or hospitals to test patients for clinical diagnosis.

Singapore-based biotech firm Veredus Laboratories has obtained the provisional authorisation from Singapore Health Sciences Authority (HSA) for its COVID-19 detection kit.

Dubbed as VereCoV Detection Kit, the device can now be used directly by laboratories or hospitals to test patients for clinical diagnosis. The kit was launched for research use only (RUO) test earlier this year.

It integrates an ultra-fast miniaturised PCR reactor for the amplification of nucleic acids and a customised microarray to qualitatively detect COVID-19 with the additional capability of detecting a subset of Severe Acute Respiratory Syndrome (SARS-CoV) within the same test.

Veredus also mentioned that this was made in collaboration with the Home Team Science and Technology Agency’s (HTX) Chemical, Biological, Radiology, Nuclear and Explosives (CBRNE) Centre of Expertise.

Also Read

Singaporeans' physical well-being at highest level since 2019

SingHealth partners with OutcomesAI to integrate AI into medical workflows

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit